Disease relevance of Contraception, Barrier

• The relationship of tubal infertility to barrier method and oral contraceptive use [1].
• STDs, IVF, and barrier contraception [2].
• The possible teratogenicity of spermicides, the risk of toxic shock syndrome with barrier methods of contraception, and controversy about the use of depot medroxyprogesterone acetate are explored [3].
• Tubal sterilization carries a somewhat higher risk of ectopic pregnancy than do barrier methods of contraception [4].

High impact information on Contraception, Barrier

• These data demonstrate that premenopausal women taking tamoxifen are potentially at risk for pregnancy and must be counseled about barrier contraception [5].
• However, the risk of pregnancy in the polyurethane group falls in the range of other barrier methods [6].
• Most recent research supports the use of barrier methods, low-dose monophasic or triphasic oral contraceptives, or progestin-only methods, at least for the short-term [7].
• The incidence of PID is higher among IUD users than among patients taking OCs or using a barrier method [8].
• Plasma beta-carotene or retinol levels did not differ among users of intrauterine contraceptive devices or barrier methods of contraception [9].

Associations of Contraception, Barrier with chemical compounds

• Supplementary contraception was given in the form of combined oral contraceptive pills, barrier methods, or injection of depot medroxyprogesterone acetate for 3 months [10].
• Fibrinolytic agents [recombinant tissue plasminogen activator (rtPA), streptokinase, and urokinase], anti-inflammatory drugs (dexamethasone and tolmetin sodium), and barrier methods [sodium carboxymethylcellulose (CMC), and sodium hyaluronate] and a control group were compared in the first phase [11].
• Beginning in the 1990s, nonlatex male condoms made of polyurethane film or synthetic elastomers were developed as alternative male barrier methods for individuals with allergies, sensitivities or preferences that prevented the consistent use of condoms made of latex [12].
• A telephone survey was conducted of 92 orthopaedic, cardiothoracic and general surgeons in the South West Region of England, regarding their use of barrier methods [13].
• BACKGROUND & OBJECTIVES: Though a number of barrier methods and potent spermicides are available, most of these have nonoxynol-9 (N-9) as the active ingredient which is observed to cause inflammation and genital ulceration on repeated use [14].

Gene context of Contraception, Barrier

• Control sera were obtained from women undergoing abortion, sterilisation, and from women practising barrier contraception [15].
• There is no difference between the protective properties of different barrier methods that are used to protect the peri-wound skin around chronic ulcers [16].
• RESULTS: Platelet-specific CD41 antibody staining showed that the purity of the platelet population recovered from this density barrier method was greater than 90% [17].
• Nevertheless, hormonal contraception confers comparable or superior efficacy compared with such other contraceptives as the intrauterine device and barrier methods and remains an appropriate option in women with epilepsy [18].

Analytical, diagnostic and therapeutic context of Contraception, Barrier

• We conclude that contraceptive users who use barrier methods that combine both a mechanical and chemical barrier, such as diaphragms, cervical caps, and condoms plus spermicides, have the clearest protection against tubal damage [1].
• In the case-control study, a reduced risk of recurrent infection was associated with tubal ligation, hormonal contraception, and barrier contraception [19].
• A risk-benefit analysis of five alternative approaches to fertility control among US women over the age of 30 was performed: tubal ligation, vasectomy, intrauterine device, barrier method (condom), and combined oral contraceptives [20].
• Various contraceptive options may be offered to perimenopausal women, including oral contraceptives, tubal ligation, intrauterine devices, barrier methods, hormonal injectables and implants [21].

References